NCT01711671 2025-08-03
A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Leap Therapeutics, Inc.
Phase 1 Completed
Clinical Trials
9 trialsNCT06504524 2025-06-27
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Pfizer
Completed
NCT05142371 2025-05-30
Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors
City of Hope Medical Center
Phase NA Completed
NCT06592222 2025-05-20
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies
Pfizer
Completed
NCT05932290 2024-10-29
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT05565391 2024-05-21
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT01995708 2024-02-09
CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT04530812 2021-11-16
Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma
Roswell Park Cancer Institute
Phase NA Completed
NCT02898064 2019-07-05
MAPP
University Hospitals of North Midlands NHS Trust
Phase NA Completed